- Home
- ANNX vs GENC Comparison
ANNX vs GENC Comparison
Compare ANNX & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- GENC
- Stock Information
- Founded
- ANNX 2011
- GENC 1894
- Country
- ANNX United States
- GENC United States
- Employees
- ANNX N/A
- GENC N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- GENC Construction/Ag Equipment/Trucks
- Sector
- ANNX Health Care
- GENC Industrials
- Exchange
- ANNX Nasdaq
- GENC Nasdaq
- Market Cap
- ANNX 253.8M
- GENC 240.4M
- IPO Year
- ANNX 2020
- GENC N/A
- Fundamental
- Price
- ANNX $2.64
- GENC $15.00
- Analyst Decision
- ANNX Strong Buy
- GENC
- Analyst Count
- ANNX 5
- GENC 0
- Target Price
- ANNX $13.00
- GENC N/A
- AVG Volume (30 Days)
- ANNX 1.6M
- GENC 39.4K
- Earning Date
- ANNX 11-13-2025
- GENC 08-08-2025
- Dividend Yield
- ANNX N/A
- GENC N/A
- EPS Growth
- ANNX N/A
- GENC N/A
- EPS
- ANNX N/A
- GENC 1.03
- Revenue
- ANNX N/A
- GENC $117,527,000.00
- Revenue This Year
- ANNX N/A
- GENC N/A
- Revenue Next Year
- ANNX N/A
- GENC N/A
- P/E Ratio
- ANNX N/A
- GENC $14.79
- Revenue Growth
- ANNX N/A
- GENC 3.90
- 52 Week Low
- ANNX $1.29
- GENC $10.80
- 52 Week High
- ANNX $7.85
- GENC $22.82
- Technical
- Relative Strength Index (RSI)
- ANNX 62.43
- GENC 50.68
- Support Level
- ANNX $2.32
- GENC N/A
- Resistance Level
- ANNX $2.70
- GENC $16.54
- Average True Range (ATR)
- ANNX 0.16
- GENC 0.55
- MACD
- ANNX 0.06
- GENC -0.72
- Stochastic Oscillator
- ANNX 87.57
- GENC 88.76
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.